References
- Insel T R, Roy B F, Cohen R M, Murphy D L. Possible development of the serotonin syndrome in man. Am J Psychiatry 1982; 139: 954–5
- Oates J A, Sjoersdma A. Neurologic effects of tryptophan in patients receiving a monoamine oxidate inhibitor. Neurology 1960; 10: 1076–8
- Thomas J M, Rubin E H. Case report of a toxic reaction from a combination of tryptophan and phenelzine. Am J Psychiatry 1984; 141: 281–3
- Levy A B, Bucher P, Votolato N. Myoclonus, hyper-refiexia and diaphoresis in patients on phenelzine-tryptophan combination treatment. Can J Psychiatry 1985; 142: 491–2
- Pope H G, Jonas J M, Hudson J I, Kafka M P. Toxic reactions to the combination of monoamine oxidate inhibitors and tryptophan. Am J Psychiatry 1985; 142: 491–2
- Price W A, Zimmer B, Kucas P. Serotonin syndrome: a case report. J Clin Pharmacol 1986; 26: 77–8
- Guze B H, Baxter L R. The serotonin syndrome: case responsive to propranolol. J Clin Psychophar-macol 1986; 6: 119–20
- Sternbach H. Danger of MAOI therapy after fluoxetine withdrawal. Lancet 1988; 2: 850–1
- Kline S S, Mauro L S, Scala-Barnett D M, Zick Serotonin D. syndrom versus neuroleptic malignant syndrome as a cause of death. Clin Pharmacokinet 1989; 8: 510–4
- Addonizio G, Susman V L, Roth S D. Neuroleptic malignant syndrome. Review and analysis of 115 cases. Biol Psychiatry 1987; 22: 1004–20
- Steiner W, Fontaine R. Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports. Biol Psychiatry 1986; 21: 1067–71
- Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148: 705–13
- Goodwin G M, De Souza R J, Wood A J, Green A R. The enhancement by lithium of the 5-HT 1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism. Psychopharmacology 1986; 90: 488–93
- Goodwin G M, De Souza R J, Green A R. Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT 1A receptor-mediated hypothermia and serotonin syndrome by 8-OH-DPAT in the rat. Psychopharmacology (Berlin) 1987; 91: 500–5
- Ikeda M, Mikuni M, Nishikawa T, Takahachi K. A neurochemical study of a new mutant mouse presenting myoclonuslike involuntary movement: a possible model of spontaneous serotonergic hyperactivity. Brain Res 1989; 495: 337–48
- Blier P, de Montigny C, Chaput Y. A role for the serotonin in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry 1990; 51: 14–20